Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Feb;65(2):564–570. doi: 10.1128/iai.65.2.564-570.1997

Th1 and Th2 cytokines in mice with invasive aspergillosis.

E Cenci 1, S Perito 1, K H Enssle 1, P Mosci 1, J P Latgé 1, L Romani 1, F Bistoni 1
PMCID: PMC176097  PMID: 9009314

Abstract

With a murine model of invasive aspergillosis we investigated cytokine production by CD4+ T helper cells and the effects of cytokine administration or neutralization on the course and outcome of infection. Patterns of susceptibility and resistance to infection were obtained with different strains of mice injected with different inocula of Aspergillus fumigatus conidia. Mice surviving the primary infection also resisted a subsequent lethal infection that was associated with production of gamma interferon by CD4+ T splenocytes. Impaired neutrophil antifungal activity, observed in susceptible mice, was concomitant with a predominant production of interleukin-4 (IL-4) by CD4+ splenocytes. In these mice, exogenous administration of IL-12 failed to induce resistance to infection; in contrast, treatment with soluble IL-4 receptor cured more than 70% of the mice from primary infection and resulted in the onset of acquired resistance to a subsequent lethal infection. These findings indicate that in murine invasive aspergillosis, production of IL-4 by CD4+ T cells may be one major factor discriminating susceptibility and resistance to infection.

Full Text

The Full Text of this article is available as a PDF (952.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernhisel-Broadbent J., Camargo E. E., Jaffe H. S., Lederman H. M. Recombinant human interferon-gamma as adjunct therapy for Aspergillus infection in a patient with chronic granulomatous disease. J Infect Dis. 1991 Apr;163(4):908–911. doi: 10.1093/infdis/163.4.908. [DOI] [PubMed] [Google Scholar]
  2. Bodey G. P., Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis. 1989 May;8(5):413–437. doi: 10.1007/BF01964057. [DOI] [PubMed] [Google Scholar]
  3. Cenci E., Romani L., Mencacci A., Spaccapelo R., Schiaffella E., Puccetti P., Bistoni F. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol. 1993 May;23(5):1034–1038. doi: 10.1002/eji.1830230508. [DOI] [PubMed] [Google Scholar]
  4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  5. Cohen M. S., Isturiz R. E., Malech H. L., Root R. K., Wilfert C. M., Gutman L., Buckley R. H. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med. 1981 Jul;71(1):59–66. doi: 10.1016/0002-9343(81)90259-x. [DOI] [PubMed] [Google Scholar]
  6. Denning D. W., Follansbee S. E., Scolaro M., Norris S., Edelstein H., Stevens D. A. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med. 1991 Mar 7;324(10):654–662. doi: 10.1056/NEJM199103073241003. [DOI] [PubMed] [Google Scholar]
  7. Dixon D. M., Polak A., Walsh T. J. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infect Immun. 1989 May;57(5):1452–1456. doi: 10.1128/iai.57.5.1452-1456.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gerson S. L., Talbot G. H., Hurwitz S., Strom B. L., Lusk E. J., Cassileth P. A. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med. 1984 Mar;100(3):345–351. doi: 10.7326/0003-4819-100-3-345. [DOI] [PubMed] [Google Scholar]
  9. Gustafson T. L., Schaffner W., Lavely G. B., Stratton C. W., Johnson H. K., Hutcheson R. H., Jr Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis. 1983 Aug;148(2):230–238. doi: 10.1093/infdis/148.2.230. [DOI] [PubMed] [Google Scholar]
  10. Jaton-Ogay K., Paris S., Huerre M., Quadroni M., Falchetto R., Togni G., Latgé J. P., Monod M. Cloning and disruption of the gene encoding an extracellular metalloprotease of Aspergillus fumigatus. Mol Microbiol. 1994 Dec;14(5):917–928. doi: 10.1111/j.1365-2958.1994.tb01327.x. [DOI] [PubMed] [Google Scholar]
  11. Khoo S. H., Denning D. W. Invasive aspergillosis in patients with AIDS. Clin Infect Dis. 1994 Aug;19 (Suppl 1):S41–S48. doi: 10.1093/clinids/19.supplement_1.s41. [DOI] [PubMed] [Google Scholar]
  12. Knutsen A. P., Mueller K. R., Levine A. D., Chouhan B., Hutcheson P. S., Slavin R. G. Asp f I CD4+ TH2-like T-cell lines in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol. 1994 Aug;94(2 Pt 1):215–221. doi: 10.1016/0091-6749(94)90043-4. [DOI] [PubMed] [Google Scholar]
  13. Kurup V. P., Choi H., Murali P. S., Coffman R. L. IgE and eosinophil regulation in a murine model of allergic aspergillosis. J Leukoc Biol. 1994 Nov;56(5):593–598. doi: 10.1002/jlb.56.5.593. [DOI] [PubMed] [Google Scholar]
  14. Kurup V. P., Mauze S., Choi H., Seymour B. W., Coffman R. L. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J Immunol. 1992 Jun 15;148(12):3783–3788. [PubMed] [Google Scholar]
  15. Lehmann P. F., White L. O. Acquired immunity to Aspergillus fumigatus. Infect Immun. 1976 Apr;13(4):1296–1298. doi: 10.1128/iai.13.4.1296-1298.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lehmann P. F., White L. O. Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice. Infect Immun. 1975 Nov;12(5):987–992. doi: 10.1128/iai.12.5.987-992.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Levitz S. M., Diamond R. D. A rapid colorimetric assay of fungal viability with the tetrazolium salt MTT. J Infect Dis. 1985 Nov;152(5):938–945. doi: 10.1093/infdis/152.5.938. [DOI] [PubMed] [Google Scholar]
  18. Michaliszyn E., Sénéchal S., Martel P., de Repentigny L. Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages. Infect Immun. 1995 May;63(5):2075–2078. doi: 10.1128/iai.63.5.2075-2078.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Monod M., Paris S., Sarfati J., Jaton-Ogay K., Ave P., Latgé J. P. Virulence of alkaline protease-deficient mutants of Aspergillus fumigatus. FEMS Microbiol Lett. 1993 Jan 1;106(1):39–46. doi: 10.1111/j.1574-6968.1993.tb05932.x. [DOI] [PubMed] [Google Scholar]
  20. Murali P. S., Dai G., Kumar A., Fink J. N., Kurup V. P. Aspergillus antigen-induced eosinophil differentiation in a murine model. Infect Immun. 1992 May;60(5):1952–1956. doi: 10.1128/iai.60.5.1952-1956.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nagai H., Guo J., Choi H., Kurup V. Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J Infect Dis. 1995 Dec;172(6):1554–1560. doi: 10.1093/infdis/172.6.1554. [DOI] [PubMed] [Google Scholar]
  22. Palmer L. B., Greenberg H. E., Schiff M. J. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax. 1991 Jan;46(1):15–20. doi: 10.1136/thx.46.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Paris S., Monod M., Diaquin M., Lamy B., Arruda L. K., Punt P. J., Latgé J. P. A transformant of Aspergillus fumigatus deficient in the antigenic cytotoxin ASPFI. FEMS Microbiol Lett. 1993 Jul 15;111(1):31–36. doi: 10.1111/j.1574-6968.1993.tb06357.x. [DOI] [PubMed] [Google Scholar]
  24. Pitrak D. L., Bak P. M., DeMarais P., Novak R. M., Andersen B. R. Depressed neutrophil superoxide production in human immunodeficiency virus infection. J Infect Dis. 1993 Jun;167(6):1406–1410. doi: 10.1093/infdis/167.6.1406. [DOI] [PubMed] [Google Scholar]
  25. Pollock J. D., Williams D. A., Gifford M. A., Li L. L., Du X., Fisherman J., Orkin S. H., Doerschuk C. M., Dinauer M. C. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat Genet. 1995 Feb;9(2):202–209. doi: 10.1038/ng0295-202. [DOI] [PubMed] [Google Scholar]
  26. Puccetti P., Mencacci A., Cenci E., Spaccapelo R., Mosci P., Enssle K. H., Romani L., Bistoni F. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J Infect Dis. 1994 Jun;169(6):1325–1331. doi: 10.1093/infdis/169.6.1325. [DOI] [PubMed] [Google Scholar]
  27. Rex J. H., Bennett J. E., Gallin J. I., Malech H. L., DeCarlo E. S., Melnick D. A. In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae. J Infect Dis. 1991 Apr;163(4):849–852. doi: 10.1093/infdis/163.4.849. [DOI] [PubMed] [Google Scholar]
  28. Rinaldi M. G. Invasive aspergillosis. Rev Infect Dis. 1983 Nov-Dec;5(6):1061–1077. doi: 10.1093/clinids/5.6.1061. [DOI] [PubMed] [Google Scholar]
  29. Roilides E., Holmes A., Blake C., Pizzo P. A., Walsh T. J. Impairment of neutrophil antifungal activity against hyphae of Aspergillus fumigatus in children infected with human immunodeficiency virus. J Infect Dis. 1993 Apr;167(4):905–911. doi: 10.1093/infdis/167.4.905. [DOI] [PubMed] [Google Scholar]
  30. Roilides E., Uhlig K., Venzon D., Pizzo P. A., Walsh T. J. Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun. 1993 Apr;61(4):1185–1193. doi: 10.1128/iai.61.4.1185-1193.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Romani L., Cenci E., Mencacci A., Spaccapelo R., Grohmann U., Puccetti P., Bistoni F. Gamma interferon modifies CD4+ subset expression in murine candidiasis. Infect Immun. 1992 Nov;60(11):4950–4952. doi: 10.1128/iai.60.11.4950-4952.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Romani L., Howard D. H. Mechanisms of resistance to fungal infections. Curr Opin Immunol. 1995 Aug;7(4):517–523. doi: 10.1016/0952-7915(95)80097-2. [DOI] [PubMed] [Google Scholar]
  33. Romani L., Mencacci A., Cenci E., Spaccapelo R., Mosci P., Puccetti P., Bistoni F. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol. 1993 Feb 1;150(3):925–931. [PubMed] [Google Scholar]
  34. Romani L., Mencacci A., Grohmann U., Mocci S., Mosci P., Puccetti P., Bistoni F. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med. 1992 Jul 1;176(1):19–25. doi: 10.1084/jem.176.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Romani L., Mencacci A., Tonnetti L., Spaccapelo R., Cenci E., Puccetti P., Wolf S. F., Bistoni F. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J Immunol. 1994 Dec 1;153(11):5167–5175. [PubMed] [Google Scholar]
  36. Romani L., Mocci S., Bietta C., Lanfaloni L., Puccetti P., Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun. 1991 Dec;59(12):4647–4654. doi: 10.1128/iai.59.12.4647-4654.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Romani L., Puccetti P., Bistoni F. Biological role of Th cell subsets in candidiasis. Chem Immunol. 1996;63:115–137. [PubMed] [Google Scholar]
  38. Romani L., Puccetti P., Mencacci A., Cenci E., Spaccapelo R., Tonnetti L., Grohmann U., Bistoni F. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol. 1994 Apr 1;152(7):3514–3521. [PubMed] [Google Scholar]
  39. Saiki R. K., Scharf S., Faloona F., Mullis K. B., Horn G. T., Erlich H. A., Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science. 1985 Dec 20;230(4732):1350–1354. doi: 10.1126/science.2999980. [DOI] [PubMed] [Google Scholar]
  40. Schaffner A., Douglas H., Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J Clin Invest. 1982 Mar;69(3):617–631. doi: 10.1172/JCI110489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Tang C. M., Cohen J., Krausz T., Van Noorden S., Holden D. W. The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect Immun. 1993 May;61(5):1650–1656. doi: 10.1128/iai.61.5.1650-1656.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Weinberger M., Elattar I., Marshall D., Steinberg S. M., Redner R. L., Young N. S., Pizzo P. A. Patterns of infection in patients with aplastic anemia and the emergence of Aspergillus as a major cause of death. Medicine (Baltimore) 1992 Jan;71(1):24–43. doi: 10.1097/00005792-199201000-00003. [DOI] [PubMed] [Google Scholar]
  43. Williams D. M., Weiner M. H., Drutz D. J. Immunologic studies of disseminated infection with Aspergillus fumigatus in the nude mouse. J Infect Dis. 1981 May;143(5):726–733. doi: 10.1093/infdis/143.5.726. [DOI] [PubMed] [Google Scholar]
  44. de Repentigny L., Petitbois S., Boushira M., Michaliszyn E., Sénéchal S., Gendron N., Montplaisir S. Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect Immun. 1993 Sep;61(9):3791–3802. doi: 10.1128/iai.61.9.3791-3802.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES